Higher expression of c‐Myc or low levels of LMNA were also correlated with worse prognosis of clinical cases suffering from B‐cell lymphoma, colon carcinoma, diffuse large B‐cell lymphoma, glioma, melanoma, osteosarcoma or sarcoma (Figure S10). Here, MYC is linked to diffuse large B-cell lymphoma.